With the transaction, Galapagos has now completed the integration of BioFocus DPI’s activities worldwide. The San Diego facility currently employs 40 people and provides medicinal chemistry and custom
In the study, 118 patients were randomized on a 1:1 basis to receive naproxcinod or naproxen, with escalating doses every three weeks. The trial included three doses of
According to the company, the new and improved microarrays allow researchers to perform their own capture experiment and perform sequencing of enriched regions using next-generation technology such as
A linear accelerator is a key component in radiation therapy systems used to create high-energy x-rays for cancer treatments. The linear accelerators designed, developed and manufactured by Twin
Restorelle Y is said to be constructed with a physiologically compatible mesh material – Smartmesh technology – which was designed by surgeons specifically for the female anatomy and
As part of the agreement, Inlight president and co-founder Shlomo Assa will join the Syneron management team. Mr Assa brings deep experience in the laser device industry, previously
The CYP2C9 gene is important in its involvement in the metabolism of 10% of all drugs, including non-steroidal anti-inflammatory drugs (eg celecoxib, ibuprofen), anti-coagulants (eg warfarin), anti-epileptic agents
The Pegasus Pharmaceuticals’s R&D Group has developed a new version of its HeartVue 6S System which is designed specifically for the continuous monitoring of heart conditions in emergency
Under the terms of the merger, which is a stock-for-stock merger intended to qualify as a tax-free reorganization, all outstanding shares of Cornerstone BioPharma’s common stock were converted
The Phase III evaluation of Hematide for anemia correction in chronic renal failure (Pearl 2) is fully enrolled with over 490 non-dialysis patients from over 60 sites in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.